30
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512564
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Créer
Create a timeline
Public timelines
Library
FAQ

1 janv. 2014 - Pembrolizumab

Description:

Pembrolizumab is approved for advanced melanoma treatment by the FDA. This monoclonal antibody blocks a protein called PD1's activity on immune cells, which increases the strength of the immune response to cancer.

Ajouté au bande de temps:

Cancer

ByTrinity Ozias
14 nov. 2019

Date:

1 janv. 2014
Maintenaint
~ Il y a 10 ans
About & FeedbackUn accordConfidentialitéBibliothèque
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on Trustpilot.com